CANESTEN 3 VAGINAL TABLET COMBI-PAK 200 MG — DIN 02150921
CLOTRIMAZOLE : 200 MG CLOTRIMAZOLE : 1 % · BAYER INC CONSUMER CARE · SUPPOSITORY ; CREAM · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is CANESTEN 3 VAGINAL TABLET COMBI-PAK?
CANESTEN 3 VAGINAL TABLET COMBI-PAK 200 MG contains CLOTRIMAZOLE : 200 MG CLOTRIMAZOLE : 1 %. It is listed in the Health Canada Drug Product Database under DIN 02150921, held by BAYER INC CONSUMER CARE, supplied as SUPPOSITORY ; CREAM for VAGINAL ; TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 02-Aug-2007. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
How much does Clotrimazole cost around the world?
Clotrimazole is listed on 10 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Bahrain publishes a retail (max); Greece publishes a producer price (ex-factory). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| South Africa | single exit price | 41 | 50 | ZAR███.██ |
| United States | acquisition | 5 | 31 | USD███.██ |
| Saudi Arabia | public | 19 | 22 | SAR███.██ |
| Australia | ex-manufacturer | 10 | 10 | AUD███.██ |
| Bahrain | retail (max) | 6 | 10 | BHD███.██ |
| Morocco | PPV (public price) | 3 | 9 | MAD███.██ |
| United Arab Emirates | public | 7 | 7 | AED███.██ |
| Greece | producer price (ex-factory) | 3 | 3 | EUR███.██ |
| Luxembourg | reimbursement | 3 | 3 | EUR███.██ |
| United Kingdom | hospital | 2 | 2 | GBP███.██ |
147 pack listings across 99 brand entries and 9 price bases, refreshed 10 Sep 2026. Ranges span every Clotrimazole pack in that market, so a high figure is usually a larger pack rather than the same product.
This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.
Is there a generic Clotrimazole in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
6 holders have a Canadian DIN containing Clotrimazole, across 36 DINs, of which 19 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| BAYER INC | 13 | 12 | CANESTEN 1 DAY INTERNAL CREAM, CANESTEN 3 DAY INTERNAL CREAM, CANESTEN 6 DAY INTERNAL CREAM, CANESTEN COMBI 1 DAY, CANESTEN COMBI 1 DAY COMFORTAB + EXTRA STRENGTH EXTERNAL CREAM, +8 more | Sourceable in Canada |
| TARO PHARMACEUTICALS INC | 9 | 7 | CLOTRIMADERM EXTERNAL CREAM, CLOTRIMADERM VAGINAL 3, CLOTRIMADERM VAGINAL 6, CLOTRIMAZOLE EXTERNAL ANTIFUNGAL CREAM, CLOTRIMAZOLE EXTERNAL CREAM, +4 more | Sourceable in Canada |
| MILES CANADA INC. - CONSUMER HEALTH CARE DIVISION | 5 | 0 | CANESTEN 2% VAGINAL CREAM, CANESTEN 200 MG VAGINAL INSERTS, CANESTEN COMBI-PAK 1 DAY THERAPY, CANESTEN CRM 1% VAG, CANESTEN VAGINAL INSERTS 100MG | No marketed DIN |
| BOEHRINGER INGELHEIM (CANADA) LTD LTEE | 4 | 0 | MYCLO CRM 50MG, MYCLO TAB 100MG, MYCLO-GYNE CREAM 1%, MYCLO-GYNE INSERTS | No marketed DIN |
| BAYER INC CONSUMER CARE | 3 | 0 | CANESTEN 1 VAGINAL TABLET COMBI-PAK, CANESTEN 100MG VAGINAL INSERTS, CANESTEN 3 VAGINAL TABLET COMBI-PAK | No marketed DIN |
| PRESTIGE PHARMA INC | 2 | 0 | NEO-ZOL VAGINAL CREAM 1%, NEO-ZOL VAGINAL CREAM 2% | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 200 MG |
|---|---|
| Dosage form | SUPPOSITORY ; CREAM |
| Route | VAGINAL ; TOPICAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Clotrimazole |
|---|---|
| ATC code | G01AF02 |
| AHFS class | 84:04.08.08 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02150921 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2150921 |
| Brand name | CANESTEN 3 VAGINAL TABLET COMBI-PAK |
| Generic / active ingredient | CLOTRIMAZOLE : 200 MG CLOTRIMAZOLE : 1 % |
| Market authorization holder | BAYER INC CONSUMER CARE |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | G01AF02 |
| ATC anatomical main group | G — Genito-urinary system and sex hormones |
| ATC therapeutic subgroup | G01AF |
| Current status | CANCELLED POST MARKET |
| Status date | 02-Aug-2007 |
| Original market date | 1995-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
19 of 36 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| CANESTEN 1 DAY INTERNAL CREAM | 10 % | CREAM | BAYER INC | MARKETED | 02150883 |
| CANESTEN 3 DAY INTERNAL CREAM | 2 % | CREAM | BAYER INC | MARKETED | 02150905 |
| CANESTEN 6 DAY INTERNAL CREAM | 1 % | CREAM | BAYER INC | MARKETED | 02150891 |
| CANESTEN COMBI 1 DAY | 1 % | CREAM ; VAGINAL TABLET ; KIT | BAYER INC | MARKETED | 02264102 |
| CANESTEN COMBI 1 DAY INTERNAL + EXTERNAL CREAMS | 10 % | KIT ; CREAM | BAYER INC | MARKETED | 02230509 |
| CANESTEN COMBI 1 DAY SOFT CAPSULE + EXTRA STRENGTH EXTERNAL CREAM | 500 MG | KIT ; VAGINAL CAPSULE ; CREAM | BAYER INC | MARKETED | 02547260 |
| CANESTEN COMBI 3 DAY | 200 MG | KIT ; VAGINAL TABLET ; CREAM | BAYER INC | MARKETED | 02264099 |
| CANESTEN COMFORTAB 1 | 500 MG | VAGINAL TABLET | BAYER INC | MARKETED | 02150859 |
| CANESTEN COMFORTAB 3 | 200 MG | VAGINAL TABLET | BAYER INC | MARKETED | 02150840 |
| CANESTEN EXTERNAL CREAM | 1 % | CREAM | BAYER INC | MARKETED | 02311720 |
2 · Same class — other molecules in ATC G01AF
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Clotrimazole | CANESTEN 1 DAY INTERNAL CREAM · CANESTEN 1 VAGINAL TABLET COMBI-PAK · CANESTEN 100MG VAGINAL INSERTS · CANESTEN 2% VAGINAL CREAM · +32 more | 36 | 19 | Yes |
| Miconazole | MICONAZOLE 3 DAY OVULE TREATMENT 400MG · MICONAZOLE 7 - CRM VAG 2% · MICONAZOLE NITRATE VAGINAL CREAM 2% · MICONAZOLE NITRATE VAGINAL CREAM USP, 2% · +10 more | 14 | 6 | Yes |
| Metronidazole | FLAGYL · FLAGYL 500 500MG · NIDAGEL | 3 | 1 | Yes |
| Tioconazole | GYNECURE COM.PK.VAG ONT6.5%VULVAR CRM1% W/W · GYNECURE COM.PK.VAG OVULE300MG VULV.CRM1%W/W · GYNECURE EXTERNAL CREAM 1% (REFILL) · GYNECURE TANDEMPK.VAG ONT6.5%/VULV.CRM1%-W/W · +3 more | 7 | 0 | Not in Canada |
| Butoconazole | GYNAZOLE.1 | 1 | 0 | Not in Canada |
| Econazole | ECOSTATIN VAGINAL OVULE 150MG | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC G01A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| G01AA | Clindamycin · Nystatin · Nystatin, Combinations | 13 | 2 |
| G01AC | Clioquinol, Combinations · Dequalinium · Diiodohydroxyquinoline, Combinations · Oxyquinoline | 5 | 1 |
| G01AG | Terconazole | 5 | 1 |
| G01AE | Combinations Of Sulfonamides · Sulfonamides | 2 | 0 |
| G01AX | Other Antiinfectives And Antiseptics · Povidone-Iodine | 8 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is CANESTEN 3 VAGINAL TABLET COMBI-PAK called?
The same molecule, Clotrimazole, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| CANESTEN | Latin | Bahrain, Morocco |
| GYNO CANESTEN | Latin | Morocco |
| Xeraspor T Cream | Latin | South Africa |
| A-Por | Latin | South Africa |
| CANDID DUSTING POWDER | Latin | Bahrain |
| Canesten Vaginal Cream | Latin | South Africa |
| CLOMITER | Latin | Morocco |
| Covospor | Latin | South Africa |
| Fungispore | Latin | South Africa |
| Fungistop Vaginal | Latin | South Africa |
| Innospore | Latin | South Africa |
| Adco-Normospor | Latin | South Africa |
| Adco-Normospor Vaginal Cream | Latin | South Africa |
| Canalba | Latin | South Africa |
| Canalbavag | Latin | South Africa |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
What is Clotrimazole called in other languages?
Buyers, prescribers and procurement teams outside Canada often search for the ingredient in their own script. These are phonetic renderings of the ingredient name Clotrimazole, published to help those searches reach this page.
| Language | Clotrimazole |
|---|---|
| Arabic العربية | كلوتريمازول |
| Chinese (Simplified) 简体中文 | 克霉唑 |
| Russian Русский | Клотримазол |
| Spanish Español | Clotrimazol |
| French Français | Clotrimazole |
| Portuguese Português | Clotrimazol |
| German Deutsch | Clotrimazol |
| Japanese 日本語 | クロトリマゾール |
These are transliterations of the ingredient name, generated automatically and published only where two independent checks agreed. They are not registered local trade names and carry no marketing authorisation in any market. Always confirm a product against its local registration before ordering.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.